Skip to Content

anaplastic lymphoma kinase gene rearranged non-small-cell lung

 

Definition: A fusion protein resulting from the rearrangement of the EML4 gene with the ALK gene, present in approximately 5% of non-small-cell lung cancers, primarily adenocarcinomas. This fusion protein is a target of ALK tyrosine kinase inhibitors in the treatment of these tumors.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.

Hide